ALGER ASSOCIATES INC 13D and 13G filings for Puma Biotechnology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-11-10 4:08 pm Sale | 2021-10-31 | 13G | Puma Biotechnology, Inc. PBYI | ALGER ASSOCIATES INC | 890,396 2.180% | -2,525,607![]() (-73.93%) | Filing |
2021-02-16 4:51 pm Purchase | 2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI | ALGER ASSOCIATES INC | 3,416,003 8.590% | 3,416,003![]() (New Position) | Filing |